TDC
SGRY icon

Thompson Davis & Co’s Surgery Partners SGRY Stock Holding History

Thompson Davis & Co’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-250
Closed -$4K – 780
2018
Q2 		$4K Sell
250
-125
-33% -$2.1K 0.01% 545
2018
Q1 		$6K Buy
375
+125
+50% +$1.95K 0.02% 462
2017
Q4 		$3K Sell
250
-750
-75% -$7.17K 0.01% 585
2017
Q3 		$10K Buy
1,000
+500
+100% +$7.15K 0.02% 693
2017
Q2 		$11K Buy
+500
New +$10.3K 0.02% 637
2016
Q4 		– Sell
-500
Closed -$10K – 1196
2016
Q3 		$10K Hold
500
– – 0.02% 667
2016
Q2 		$9K Buy
+500
New +$7.44K 0.01% 677
2016
Q1 		– Sell
-125
Closed -$3K – 1155
2015
Q4 		$3K Buy
+125
New +$2.39K ﹤0.01% 956

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thompson Davis & Co's SGRY Position: Q3 2018 in Review

Thompson Davis & Co sold out of Surgery Partners (SGRY) in Q3 2018, closing a stake of 250 shares — an estimated $4K sold.

Thompson Davis & Co first reported a position in SGRY in Q4 2015 and held it in 8 quarters. The position peaked at $11K in Q2 2017. 79 funds tracked by Wall St. Rank hold SGRY as of Q3 2018.

  • Thompson Davis & Co reported no remaining Surgery Partners position as of Q3 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 250 Surgery Partners shares in Q3 2018, an estimated $4K.
  • Thompson Davis & Co first reported a position in Surgery Partners in Q4 2015 and held it in 8 quarters.
  • Thompson Davis & Co's Surgery Partners position peaked at $11K in Q2 2017.
  • 79 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.